We propose a continuation of the North Carolina Ovarian Cancer study (NCOCS), a molecular epidemiologic study of primary epithelial ovarian cancer. This is a population-based, case-control study in a 48 county region of North Carolina. We will have enrolled approximately 500 invasive epithelial ovarian cancer cases by the start of the proposed study, and plan to enroll 300 additional cases. The central goal of the NCOCS is to define subsets of epithelial ovarian cancer on the basis of the molecular signatures associated with specific disease causing exposures. The proposed renewal application will focus on the role of genes in DNA damage response pathways in the development of ovarian cancer. We hypothesize that spontaneous errors of DNA synthesis during cell proliferation is induced by ovulation leading to tumor development and individual variation in the efficiency of repairing damaged DNA due to variants in genes in DNA damage response pathways may be associated with ovarian cancer risk. In addition we hypothesize somatic p53 mutations, the most common molecular alteration in ovarian cancers, may interact with variants in DNA damage and repair genes resulting in failed DNA repair.
The specific aims are: 1) To continue accrual of ovarian cancer cases and controls to achieve a sample of 800 invasive ovarian cancer cases and 800 controls; 2) To examine the relationship between ovarian cancer risk and polymorphisms in DNA damage and repair genes including XRCC1, XPD, BARD1, BACH1, GADD45, and BASC. We will also examine polymorphisms in genes involved in the p53 DNA damage checkpoint including p21, MDM2, AFR, and PIG3 genes; and 3) To develop a high throughput approach to identification of single nucleotide polymorphisms (SNPs) that affect ovarian cancer susceptibility. The joint consideration of epidemiologic risk factors and molecular characteristics should enhance our understanding of the etiology of ovarian cancer. Elucidation of the role of reproductive and environmental risk factors and genetic susceptibility could facilitate identification of high-risk women who would be ideal candidates for preventive interventions.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA076016-07
Application #
6806049
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Program Officer
Seminara, Daniela
Project Start
1998-09-01
Project End
2008-08-31
Budget Start
2004-09-01
Budget End
2005-08-31
Support Year
7
Fiscal Year
2004
Total Cost
$638,080
Indirect Cost
Name
Duke University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Harris, Holly R; Babic, Ana; Webb, Penelope M et al. (2018) Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 27:174-182
Lu, Yingchang; Beeghly-Fadiel, Alicia; Wu, Lang et al. (2018) A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res 78:5419-5430
Peres, Lauren C; Risch, Harvey; Terry, Kathryn L et al. (2018) Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. Int J Epidemiol 47:460-472
Peres, Lauren C; Cushing-Haugen, Kara L; Anglesio, Michael et al. (2018) Histotype classification of ovarian carcinoma: A comparison of approaches. Gynecol Oncol 151:53-60
Liu, Gang; Mukherjee, Bhramar; Lee, Seunggeun et al. (2018) Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence. Am J Epidemiol 187:366-377
Praestegaard, Camilla; Jensen, Allan; Jensen, Signe M et al. (2017) Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies. Int J Cancer 140:2422-2435
Glubb, Dylan M; Johnatty, Sharon E; Quinn, Michael C J et al. (2017) Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci. Oncotarget 8:64670-64684
Minlikeeva, Albina N; Freudenheim, Jo L; Eng, Kevin H et al. (2017) History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 26:1470-1473
Minlikeeva, Albina N; Freudenheim, Jo L; Cannioto, Rikki A et al. (2017) History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report. Br J Cancer 117:1063-1069
Kar, Siddhartha P; Adler, Emily; Tyrer, Jonathan et al. (2017) Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci. Br J Cancer 116:524-535

Showing the most recent 10 out of 102 publications